{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:46:13Z","timestamp":1792813573501,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007613","name":"Majmaah University","doi-asserted-by":"publisher","award":["R-2025-2128"],"award-info":[{"award-number":["R-2025-2128"]}],"id":[{"id":"10.13039\/501100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.micpath.2025.108173","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:49:28Z","timestamp":1762829368000},"page":"108173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pathogen-specific drug metabolism in tuberculosis: Enzymes, metabolic pathways, and new horizons in therapeutic development"],"prefix":"10.1016","volume":"210","author":[{"given":"Periyasamy","family":"Vijayalakshmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Alfaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendran","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrabose","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.108173_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1194923","article-title":"Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible?","volume":"14","author":"Jacobo-Delgado","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.micpath.2025.108173_bib2","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1016\/S1473-3099(24)00761-8","article-title":"[Title undefined]","volume":"24","author":"Burki","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2025.108173_bib3","first-page":"38","article-title":"The global tuberculosis epidemic and tuberculosis control, UN Millenn","volume":"TB","year":"2013","journal-title":"Dev. Libr.: Invest. Strateg. Rev. Glob. Incid."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136222","article-title":"The knowns and unknowns of latent Mycobacterium tuberculosis infection","volume":"131","author":"Boom","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/lungindia.lungindia_182_22","article-title":"Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extrapulmonary (EP) MDR-TB at a tertiary care center in Mumbai in pre-Bedaquiline era","volume":"40","author":"Utpat","year":"2023","journal-title":"Lung India"},{"key":"10.1016\/j.micpath.2025.108173_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/1393003.congress-2017.OA1944","article-title":"Multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB): global response","author":"Falzon","year":"2017","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of MDR-, XDR-, and incurable tuberculosis","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"15","key":"10.1016\/j.micpath.2025.108173_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.micpath.2025.108173_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1101320","article-title":"Nanoconstructs for theranostic application in cancer: challenges and strategies to enhance delivery","volume":"14","author":"Mishra","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.121.000744","article-title":"Unusual biotransformation reactions of drugs and drug candidates","volume":"51","author":"Isin","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.micpath.2025.108173_bib12","doi-asserted-by":"crossref","DOI":"10.5772\/29996","article-title":"Phase II drug metabolism","author":"Janov","year":"2012","journal-title":"Top. Drug Metab"},{"key":"10.1016\/j.micpath.2025.108173_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-6147(82)91102-6","article-title":"Extrahepatic metabolism of drugs and other foreign compounds","volume":"3","author":"Robert Jondore","year":"1982","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-6997(24)01340-1","article-title":"Role of pharmacokinetics and metabolism in drug discovery and development","volume":"49","author":"Lin","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.micpath.2025.108173_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jgar.2019.03.009","article-title":"Drug resistance profile of Mycobacterium tuberculosis and predictors associated with development of drug resistance","volume":"18","author":"Hameed","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35475-4","article-title":"Regulation and overexpression studies of YidC in Mycobacterium tuberculosis","volume":"8","author":"Thakur","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1473-3099(16)00047-5","article-title":"Bedaquiline plus delamanid for XDR tuberculosis","volume":"16","author":"Lach\u00e2tre","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"21","key":"10.1016\/j.micpath.2025.108173_bib19","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cbdv.200790032","volume":"4","author":"Testa","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"6","key":"10.1016\/j.micpath.2025.108173_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/tx0002583","article-title":"Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/cmdc.200900005","article-title":"Concerning cytochromes P450: role in metabolism and toxicity of drugs and other xenobiotics","volume":"4","author":"Ingelman\u2010Sundberg","year":"2009","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/03602530600688503","article-title":"CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism","volume":"38","author":"Baer","year":"2006","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib24","volume":"118","author":"Strassburg","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.micpath.2025.108173_bib25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0090-9556(25)08811-7","article-title":"Studies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes","volume":"20","author":"Styczynski","year":"1992","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","article-title":"Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase","volume":"39","author":"Weinshilboum","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbapap.2010.05.015","article-title":"Expression and characterization of Mycobacterium tuberculosis CYP144: common themes and lessons learned in the M. tuberculosis P450 enzyme family","volume":"1814","author":"Driscoll","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200140050-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials","volume":"40","author":"Burman","year":"2001","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib29","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1074\/jbc.M708734200","article-title":"Mycobacterium tuberculosis CYP130","volume":"283","author":"Ouellet","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.micpath.2025.108173_bib30","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0090-9556(24)13665-3","article-title":"Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen","volume":"28","author":"Dong","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \"Pie\"","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.micpath.2025.108173_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-662-04383-7_6","article-title":"In vitro screening of cytochrome P450 induction potential","author":"Pelkonen","year":"2002","journal-title":"Pharmacokinet. Challenges Drug Discov."},{"issue":"7","key":"10.1016\/j.micpath.2025.108173_bib33","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/JB.187.7.2341-2347.2005","article-title":"N-Glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment","volume":"187","author":"Mahapatra","year":"2005","journal-title":"J. Bacteriol."},{"issue":"14","key":"10.1016\/j.micpath.2025.108173_bib34","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1301936","article-title":"Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria","volume":"369","author":"Bennett","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.44.4.991-996.2000","article-title":"Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites","volume":"44","author":"Nzila","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2025.108173_bib37","article-title":"Dapsone resistance in Mycobacterium leprae","volume":"71","author":"Gillis","year":"2000","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.micpath.2025.108173_bib38","series-title":"Arrayed CRISPRi and Quantitative Imaging Describe the Morphotypic Landscape of Essential Mycobacterial Genes","author":"De Wet","year":"2020"},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/1040841X.2012.749211","article-title":"Molybdenum cofactor: a key component of Mycobacterium tuberculosis pathogenesis?","volume":"40","author":"Williams","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.exppara.2013.06.015","article-title":"A novel alkyl phosphocholine-dinitroaniline hybrid molecule exhibits biological activity in vitro against Leishmania amazonensis","volume":"135","author":"Godinho","year":"2013","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0027-2013","article-title":"Structural annotation of the Mycobacterium tuberculosis proteome","volume":"2","author":"Chandra","year":"2014","journal-title":"Microbiol. Spectr."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tube.2011.01.002","article-title":"Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis","volume":"91","author":"Neyrolles","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2025.108173_bib43","series-title":"The Mycobacterial Cell Envelope","first-page":"323","article-title":"The role of mycobacterial kinases and phosphatases in growth, pathogenesis, and cell wall metabolism","author":"Tyagi","year":"2014"},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1097-2765(00)80250-6","article-title":"A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis","volume":"5","author":"Glickman","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.micpath.2025.108173_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.961921","article-title":"Tuberactinomycin antibiotics: biosynthesis, anti-mycobacterial action, and mechanisms of resistance","volume":"13","author":"Laughlin","year":"2022","journal-title":"Front. Microbiol."},{"issue":"7482","key":"10.1016\/j.micpath.2025.108173_bib47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature12799","article-title":"Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids","volume":"505","author":"Cambier","year":"2013","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.micpath.2025.108173_bib48","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.0503272102","article-title":"Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages","volume":"102","author":"Rengarajan","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib49","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1462-5822.2009.01335.x","article-title":"Mycobacterial survival strategies in the phagosome: defence against host stresses","volume":"11","author":"Ehrt","year":"2009","journal-title":"Cell. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1462-5822.2006.00705.x","article-title":"Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism","volume":"8","author":"Deretic","year":"2006","journal-title":"Cell. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2007.00545.x","article-title":"Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?","volume":"219","author":"Berrington","year":"2007","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000545","article-title":"Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2025.108173_bib53","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1017\/S1462399411002079","article-title":"Redox homeostasis in mycobacteria: the key to tuberculosis control?","volume":"13","author":"Kumar","year":"2011","journal-title":"Expet Rev. Mol. Med."},{"issue":"9","key":"10.1016\/j.micpath.2025.108173_bib54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrmicro2387","article-title":"Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?","volume":"8","author":"Behar","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"48","key":"10.1016\/j.micpath.2025.108173_bib55","doi-asserted-by":"crossref","first-page":"19371","DOI":"10.1073\/pnas.1109201108","article-title":"Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar H+-ATPase to inhibit phagosome acidification","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.micpath.2025.108173_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5980","key":"10.1016\/j.micpath.2025.108173_bib57","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don't know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"issue":"7331","key":"10.1016\/j.micpath.2025.108173_bib58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5588\/ijtld.13.0739","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis: what have we learnt?","volume":"18","author":"Yew","year":"2014","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"Ramaswamy","year":"1998","journal-title":"Tuber. Lung Dis."},{"issue":"9","key":"10.1016\/j.micpath.2025.108173_bib61","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/AAC.00204-15","article-title":"Systematic review of mutation profiles in drug-resistant Mycobacterium tuberculosis","volume":"59","author":"Ramirez-Busby","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.108173_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkw502","article-title":"Unexpected high prevalence of resistance-associated rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline","author":"Villellas","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/03602530802186389","article-title":"Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis","volume":"40","author":"McLean","year":"2008","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.abb.2009.07.011","article-title":"The Mycobacterium tuberculosis cytochrome P450 system","volume":"493","author":"Ouellet","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"issue":"5906","key":"10.1016\/j.micpath.2025.108173_bib65","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","article-title":"PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00326-24","article-title":"Functions of nitroreductases in mycobacterial physiology and drug susceptibility","volume":"207","author":"Eke","year":"2025","journal-title":"J. Bacteriol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.apsb.2016.07.014","article-title":"Isoniazid metabolism and hepatotoxicity","volume":"6","author":"Wang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"38","key":"10.1016\/j.micpath.2025.108173_bib68","doi-asserted-by":"crossref","first-page":"36285","DOI":"10.1074\/jbc.M303639200","article-title":"Identification of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of Mycobacterium species","volume":"278","author":"Kordul\u00e1kov\u00e1","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.micpath.2025.108173_bib69","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1039\/C9OB02008J","article-title":"Kinetic modelling of acyl glucuronide and glucoside reactivity and development of structure\u2013property relationships","volume":"18","author":"Bradshaw","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.micpath.2025.108173_bib70","author":"Chenge"},{"key":"10.1016\/j.micpath.2025.108173_bib71","series-title":"Crystal Structure of Mycobacterium tuberculosis Cytochrome P450 Cyp125, C2221 Crystal Form","author":"McLean","year":"2009"},{"key":"10.1016\/j.micpath.2025.108173_bib72","article-title":"DAHP synthase from Mycobacterium tuberculosis, fully inhibited by tyrosine, phenylalanine, and tryptophan","author":"Munack","year":"2015","journal-title":"Worldwide Protein Data Bank"},{"key":"10.1016\/j.micpath.2025.108173_bib73","series-title":"Carbonic Anhydrases","first-page":"449","article-title":"Carbonic anhydrases from pathogens","author":"Aspatwar","year":"2019"},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib74","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1107\/S2053230X16010943","article-title":"Crystal structure of Rv3899c(184-410), a hypothetical protein from Mycobacterium tuberculosis","volume":"72","author":"Liu","year":"2016","journal-title":"Acta Crystallogr. F: Struct. Biol. Commun."},{"issue":"6 Pt 1","key":"10.1016\/j.micpath.2025.108173_bib75","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1164\/ajrccm\/142.6_Pt_1.1467","article-title":"Pyrazinamide in the chemoprophylaxis of tuberculosis","volume":"142","author":"Mitchison","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"issue":"11","key":"10.1016\/j.micpath.2025.108173_bib76","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.5588\/ijtld.15.0389","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015","volume":"19","author":"Zhang","year":"2015","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib77","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1128\/AAC.01611-09","article-title":"Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor","volume":"54","author":"Huitric","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib78","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/AAC.01577-08","article-title":"A balancing act: efflux\/influx in mycobacterial drug resistance","volume":"53","author":"Louw","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.108173_bib79","doi-asserted-by":"crossref","unstructured":"Siu, K. (n.d.). Molecular Characterization of multi-drug Resistance Mechanisms in Mycobacterium tuberculosis [Doctoral dissertation, The University of Hong Kong]. https:\/\/doi.org\/10.5353\/th_b4607621.","DOI":"10.5353\/th_b4607621"},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkt364","article-title":"Mutation accumulation in the Mycobacterium tuberculosis genome: implications for the evolution of drug resistance","volume":"69","author":"McGrath","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib81","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/AAC.00303-06","article-title":"Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants","volume":"50","author":"Huitric","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.108173_bib82","series-title":"Handbook of Tuberculosis","first-page":"323","article-title":"Mechanisms of drug action, drug resistance and drug tolerance in Mycobacterium tuberculosis: expected phenotypes from evolutionary pressures from a highly successful pathogen","author":"Zhang","year":"2008"},{"issue":"6 Pt 1","key":"10.1016\/j.micpath.2025.108173_bib83","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1164\/ajrccm\/142.6_Pt_1.1467","article-title":"Pyrazinamide in the chemoprophylaxis of tuberculosis","volume":"142","author":"Mitchison","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2025.108173_bib84","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ng.2747","article-title":"Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis","volume":"45","author":"Farhat","year":"2013","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149326","article-title":"Ion channel blockers as antimicrobial agents, efflux inhibitors, and enhancers of macrophage killing activity against drug-resistant Mycobacterium tuberculosis","volume":"11","author":"Machado","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.micpath.2025.108173_bib86","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nm0696-662","article-title":"Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus","volume":"2","author":"Scorpio","year":"1996","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib87","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/AAC.01577-08","article-title":"A balancing act: efflux\/influx in Mycobacterial drug resistance","volume":"53","author":"Louw","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.108173_bib88","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/17425247.5.9.931","article-title":"Drug delivery approaches to overcome bacterial resistance to \u03b2-lactam antibiotics","volume":"5","author":"Abeylath","year":"2008","journal-title":"Expet Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.micpath.2025.108173_bib89","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"2018","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.micpath.2025.108173_bib90","article-title":"Redox homeostasis in mycobacteria: the key to tuberculosis control?","volume":"13","author":"Kumar","year":"2011","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.micpath.2025.108173_bib91","article-title":"Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis","author":"Omollo","year":"2019","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib93","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1086\/651377","article-title":"Efflux-pump\u2013derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol","volume":"201","author":"Srivastava","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib94","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10409238.2013.869543","article-title":"Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria","volume":"49","author":"Kester","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.micpath.2025.108173_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/9781555815783.ch4","article-title":"A comprehensive overview of mycolic acid structure and biosynthesis","author":"Marrakchi","year":"2014","journal-title":"Mycobacterial Cell Envelope"},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.coi.2013.05.005","article-title":"Inflammation in tuberculosis: interactions, imbalances and interventions","volume":"25","author":"Kaufmann","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"10.1016\/j.micpath.2025.108173_bib97","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/AAC.00269-11","article-title":"Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling","volume":"55","author":"Srivastava","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib98","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1462-2920.12320","article-title":"Three different [NiFe] hydrogenases confer metabolic flexibility in the obligate aerobe Mycobacterium smegmatis","volume":"16","author":"Berney","year":"2013","journal-title":"Environ. Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2025.108173_bib99","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"Almeida Da Silva","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.108173_bib100","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1128\/AAC.00647-15","article-title":"Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance","volume":"59","author":"Minato","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib101","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02267-16","article-title":"ATP-dependent persister formation in Escherichia coli","volume":"8","author":"Shan","year":"2017","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib102","article-title":"A revised biosynthetic pathway for the cofactor F420 in prokaryotes","volume":"10","author":"Jackson","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.micpath.2025.108173_bib103","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1586\/eri.12.103","article-title":"Is adjuvant therapy a potential road for fighting Mycobacterium tuberculosis resistance?","volume":"10","author":"Martins","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"26","key":"10.1016\/j.micpath.2025.108173_bib105","doi-asserted-by":"crossref","first-page":"14694","DOI":"10.1073\/pnas.96.26.14694","article-title":"Activity-based protein profiling: the serine hydrolases","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib106","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4155\/fmc-2018-0560","article-title":"A genetic programming-based approach to identify potential inhibitors of serine protease of Mycobacterium tuberculosis","volume":"12","author":"Kumari","year":"2019","journal-title":"Future Med. Chem."},{"issue":"9","key":"10.1016\/j.micpath.2025.108173_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00733-19","article-title":"New \u03b2-lactamase inhibitors Nacubactam and Zidebactam improve the in vitro activity of \u03b2-lactam antibiotics against Mycobacterium abscessus complex clinical isolates","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.micpath.2025.108173_bib108","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acsinfecdis.6b00135","article-title":"Small-molecule probes reveal Esterases with persistent activity in dormant and reactivating Mycobacterium tuberculosis","volume":"2","author":"Tallman","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2025.108173_bib109","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1021\/cb300112x","article-title":"Development of a selective activity-based probe for adenylating enzymes: profiling MBTA involved in Siderophore biosynthesis from Mycobacterium tuberculosis","volume":"7","author":"Duckworth","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio.2259","article-title":"Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence","volume":"13","author":"Zheng","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.micpath.2025.108173_bib111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/17460440903018857","article-title":"Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders","volume":"4","author":"Ahn","year":"2009","journal-title":"Expet Opin. Drug Discov."},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib112","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/AAC.49.5.1733-1738.2005","article-title":"Should we use N-acetyltransferase type 2 Genotyping to personalize isoniazid doses?","volume":"49","author":"Kinzig-Schippers","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib113","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00228-012-1429-9","article-title":"NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy","volume":"69","author":"Azuma","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5306","article-title":"Isocitrate lyase mediates broad antibiotic tolerance in mycobacterium tuberculosis","volume":"5","author":"Nandakumar","year":"2014","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.micpath.2025.108173_bib114","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tube.2007.05.012","article-title":"Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis","volume":"87","author":"Cho","year":"2007","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2025.108173_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114545","article-title":"Functional variability of rhesus macaque (Macaca mulatta) NAT2 gene for drug-metabolising arylamine N-acetyltransferase 2","volume":"188","author":"Boukouvala","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.micpath.2025.108173_bib116","series-title":"Proc. 5th Int. Electron. Conf. Med. Chem.","article-title":"Surface display of human cytochrome p450 enzymes 3a4, 1a2, 2c9, 2c19 and 2d6 with cytochrome P450 reductase for drug metabolism studies","volume":"6333","author":"Tian","year":"2019"},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib117","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/AAC.49.5.1733-1738.2005","article-title":"Should we use N-acetyltransferase type 2 genotype to personalize isoniazid doses?","volume":"49","author":"Kinzig-Schippers","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.108173_bib118","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.2147\/DDDT.S87131","article-title":"A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis","volume":"9","author":"Jung","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib119","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","article-title":"Functional significance of a C\u2192A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine","volume":"47","author":"Sachse","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.micpath.2025.108173_bib120","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumour necrosis factor antagonists: structure, function, and tuberculosis risks","volume":"8","author":"Wallis","year":"2008","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.108173_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003946","article-title":"Identification of host-targeted small molecules that restrict intracellular mycobacterium tuberculosis growth","volume":"10","author":"Stanley","year":"2014","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib122","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","article-title":"Host-directed therapies for infectious diseases: current status, recent progress, and future prospects","volume":"16","author":"Zumla","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2025.108173_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002287","article-title":"Fumarate reductase activity maintains an energized membrane in anaerobic mycobacterium tuberculosis","volume":"7","author":"Watanabe","year":"2011","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.micpath.2025.108173_bib125","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nprot.2017.040","article-title":"Quantitative proteomics: challenges and opportunities in basic and applied research","volume":"12","author":"Schubert","year":"2017","journal-title":"Nat. Protoc."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.78","article-title":"Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in mycobacterium tuberculosis","volume":"1","author":"Peterson","year":"2016","journal-title":"Nat. Microbiol."},{"issue":"8","key":"10.1016\/j.micpath.2025.108173_bib127","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm.1795","article-title":"A membrane protein preserves intrabacterial pH in intraphagosomal mycobacterium tuberculosis","volume":"14","author":"Vandal","year":"2008","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.micpath.2025.108173_bib128","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib129","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02073-16","article-title":"A bioengineered three-dimensional cell culture platform integrated with microfluidics to address antimicrobial resistance in tuberculosis","volume":"8","author":"Bielecka","year":"2017","journal-title":"mBio"},{"issue":"1\u20132","key":"10.1016\/j.micpath.2025.108173_bib130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.micpath.2025.108173_bib131","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nprot.2013.068","article-title":"Evaluation of the pathogenesis and treatment of mycobacterium marinum infection in zebrafish","volume":"8","author":"Takaki","year":"2013","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053657","article-title":"Human granuloma in vitro model, for TB dormancy and resuscitation","volume":"8","author":"Kapoor","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib133","doi-asserted-by":"crossref","DOI":"10.1186\/1752-0509-1-26","article-title":"Investigating the metabolic capabilities of mycobacterium tuberculosis H37Rv using the in silico strain iNJ 661 and proposing alternative drug targets","volume":"1","author":"Jamshidi","year":"2007","journal-title":"BMC Syst. Biol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108173_bib134","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1021\/ci500077v","article-title":"Looking back to the future: predicting in vivo efficacy of small molecules versus Mycobacterium tuberculosis","volume":"54","author":"Ekins","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.micpath.2025.108173_bib135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1386207323666200219120903","article-title":"In silico drug target discovery through proteome mining from M. tuberculosis: an insight into antivirulent therapy","volume":"23","author":"Bhattacharya","year":"2020","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"5","key":"10.1016\/j.micpath.2025.108173_bib136","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","article-title":"Exploiting machine learning for end-to-end drug discovery and development","volume":"18","author":"Ekins","year":"2019","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.micpath.2025.108173_bib137","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-017-0235-x","article-title":"Molecular de-novo design through deep reinforcement learning","volume":"9","author":"Olivecrona","year":"2017","journal-title":"J. Cheminf."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025008988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025008988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:25:29Z","timestamp":1773879929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025008988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":133,"alternative-id":["S0882401025008988"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108173","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogen-specific drug metabolism in tuberculosis: Enzymes, metabolic pathways, and new horizons in therapeutic development","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108173"}}